Skip to main content

Table 1 Assumptions used for sample size calculation for the first 14 weeks of life

From: Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial

Assumption

Estimated level

Two-sided significance level

0.05

Ratio of sample size early/late BCG vaccination

1

Percent of vaccinated at 14 weeks of age with severe illness

15

Percent of vaccinated at birth with severe illness

10

Risk ratio:

0.7

Risk difference

5

Total sample size (i.e., in both trial arms)

1914

  1. BCG Bacillus Calmette-Guérin